Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Journal of hematotherapy

Showing results (291-300 of 369) with videos related to

Pageof 37
Sort By:
Journal of Hematotherapy|July 23, 1999
TNF-alpha gene therapy with myeloid progenitor cells lacks the toxicities of systemic TNF-alpha therapyS C Gautam, Y X Xu, K R Pindolia, et al.
Journal of Hematotherapy|July 23, 1999
Enhancement of hematopoietic reconstitution with recombinant cytokines: effect of rhIL-6 in combination with rhGM-CSF and rhIL-3 on unmodified or T cell-depleted bone marrowM Mumcuoglu, S Slavin
Journal of Hematotherapy|July 23, 1999
Interferon as maintenance therapy in refractory malignant lymphomaA Avilés, A Talavera, N R Díaz, et al.
Journal of Hematotherapy|July 23, 1999
Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line NK-92Y K Tam, B Miyagawa, V C Ho, et al.
Journal of Hematotherapy|June 1, 1999
Ex vivo expansion of hematopoietic stem and progenitor cells: are we there yet?E F Srour, R Abonour, K Cornetta, et al.
Journal of Hematotherapy|June 1, 1999
Peripheral blood stem cell mobilization for high-dose chemotherapyT Demirer, W I Bensinger, C D Buckner
Journal of Hematotherapy|June 1, 1999
Large ex vivo expansion of human umbilical cord blood CD4+ and CD8+ T cellsD Skea, N H Chang, R Hedge, et al.
Journal of Hematotherapy|April 7, 1999
Validation of the Nordic flow cytometry standard for CD34+ cell enumeration in blood and autografts: report from the third workshop. Nordic Stem Cell Laboratory GroupH E Johnsen, J Baech, K Nikolajsen
Journal of Hematotherapy|April 7, 1999
Injury to autologous normal tissues and tumors mediated by lymphokine-activated killer (LAK) cells generated in vitro from peripheral blood mononuclear cells of glioblastoma patientsY Fujimiya, Y Suzuki, R Katakura, et al.
Journal of Hematotherapy|June 1, 1995
Culture methods for the detection of minimal tumor contamination of hematopoietic harvests: a reviewJ G Sharp, S L Mann, B Murphy, et al.
Pageof 37

Showing results (291-300 of 369) with videos related to

Sort By:
Pageof 37
Journal of Hematotherapy|July 23, 1999
TNF-alpha gene therapy with myeloid progenitor cells lacks the toxicities of systemic TNF-alpha therapyS C Gautam, Y X Xu, K R Pindolia, et al.
Journal of Hematotherapy|July 23, 1999
Enhancement of hematopoietic reconstitution with recombinant cytokines: effect of rhIL-6 in combination with rhGM-CSF and rhIL-3 on unmodified or T cell-depleted bone marrowM Mumcuoglu, S Slavin
Journal of Hematotherapy|July 23, 1999
Interferon as maintenance therapy in refractory malignant lymphomaA Avilés, A Talavera, N R Díaz, et al.
Journal of Hematotherapy|July 23, 1999
Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line NK-92Y K Tam, B Miyagawa, V C Ho, et al.
Journal of Hematotherapy|June 1, 1999
Ex vivo expansion of hematopoietic stem and progenitor cells: are we there yet?E F Srour, R Abonour, K Cornetta, et al.
Journal of Hematotherapy|June 1, 1999
Peripheral blood stem cell mobilization for high-dose chemotherapyT Demirer, W I Bensinger, C D Buckner
Journal of Hematotherapy|June 1, 1999
Large ex vivo expansion of human umbilical cord blood CD4+ and CD8+ T cellsD Skea, N H Chang, R Hedge, et al.
Journal of Hematotherapy|April 7, 1999
Validation of the Nordic flow cytometry standard for CD34+ cell enumeration in blood and autografts: report from the third workshop. Nordic Stem Cell Laboratory GroupH E Johnsen, J Baech, K Nikolajsen
Journal of Hematotherapy|April 7, 1999
Injury to autologous normal tissues and tumors mediated by lymphokine-activated killer (LAK) cells generated in vitro from peripheral blood mononuclear cells of glioblastoma patientsY Fujimiya, Y Suzuki, R Katakura, et al.
Journal of Hematotherapy|June 1, 1995
Culture methods for the detection of minimal tumor contamination of hematopoietic harvests: a reviewJ G Sharp, S L Mann, B Murphy, et al.
Pageof 37